• Home  /
  • Healthcare   /
  • MACKENZIE ALEXANDER R; Executive Vice President of Pfizer, Inc. (NYSE:PFE) sold 7350 shares

MACKENZIE ALEXANDER R; Executive Vice President of Pfizer, Inc. (NYSE:PFE) sold 7350 shares

Shares of Pfizer, Inc. (NYSE:PFE) traded between $33.82 and $34.13 and closed with +0.12% at $33.96. The Company traded 18.18 million shares as compared to its three months average volume of 17.74 million shares. The company has market value of $201.97B and PE ratio of 24.84. The company has 50-day of 33.30 and 200-day moving averages of $33.47. Additionally, stock has a Price/EPS Estimate Current Year ratio of 13.27 and its Price/EPS Estimate Next Year ratio is registered at 12.30.

Recent Insider Activity:

Currently the Insiders own 0.04% of Pfizer Inc. shares. Institutional Investors own 71.30% of company’s shares. During last three month period, the net percent change held by Institutional Investors has seen a change of -1.01%. During last six month period, the net percent change kept by insiders has seen a change of -18.05%.

In the company’s insider trading activities, MACKENZIE ALEXANDER R; Executive Vice President of Pfizer Inc. sold 7350 shares worth of $249900 in a transaction on 31 Aug 2017. In this transaction, these shares were sold at value of $34 per share, according to the information disclosed by the Securities and Exchange Commission in a Form 4 filing on 01 Sep 2017.

DAMELIO FRANK A; Executive Vice President of Pfizer Inc. sold 94409 shares worth of $3209906 in a transaction dated on 31 Aug 2017. Shares were sold at the average price of 34 per share, according to SEC Form 4 filing submitted on 01 Sep 2017.

In other transaction, READ IAN C (Chairman & CEO) sold 141193 shares on 31 Aug 2017 worth of $4800562. In this Insider Trading activity, shares were sold with per share cost of $34.

READ IAN C (Chairman & CEO) of PFE [NYSE] sold 55975 shares worth of $1903150 at the average price of $34 on31 Aug 2017.

On 21 Aug 2017, OLSON LAURIE J (Executive Vice President) sold 8064 shares at per share price of $32.7 with total value of $263693.

Analyst projected earnings per shares (EPS) of $2.76 for next Year. They forecasted earnings per share (EPS) of $2.56 for current Year and also expected EPS of $0.56 for coming quarter.

The following two tabs change content below.

Eldred Matthew

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a comment